PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of scirepAboutEditorial BoardFor AuthorsScientific Reports
 
Sci Rep. 2017; 7: 45061.
Published online 2017 March 23. doi:  10.1038/srep45061
PMCID: PMC5362882

The chemokine receptor CXCR4 promotes granuloma formation by sustaining a mycobacteria-induced angiogenesis programme

Abstract

CXC chemokine receptor 4 plays a critical role in chemotaxis and leukocyte differentiation. Furthermore, there is increasing evidence that links this receptor to angiogenesis. Using the well-established zebrafish-Mycobacterium marinum model for tuberculosis, angiogenesis was recently found to be important for the development of cellular aggregates called granulomas that contain the mycobacteria and are the hallmark of tuberculosis disease. Here, we found that initiation of the granuloma-associated proangiogenic programme requires CXCR4 signalling. The nascent granulomas in cxcr4b-deficient zebrafish embryos were poorly vascularised, which in turn also delayed bacterial growth. Suppressed infection expansion in cxcr4b mutants could not be attributed to an overall deficient recruitment of leukocytes or to different intramacrophage bacterial growth rate, as cxcr4b mutants displayed similar microbicidal capabilities against initial mycobacterial infection and the cellular composition of granulomatous lesions was similar to wildtype siblings. Expression of vegfaa was upregulated to a similar extent in cxcr4b mutants and wildtypes, suggesting that the granuloma vascularisation phenotype of cxcr4b mutants is independent of vascular endothelial growth factor.

CXCR4 is a critical chemokine receptor that controls migration and differentiation of a variety of cell types1,2. In the bone marrow, interaction of CXCR4 with its ligand CXCL12 (SDF1, stromal cell-derived factor 1) is required for retention of haematopoietic stem/progenitor cells and their complete differentiation before release into circulation3,4. During inflammatory responses, CXCR4 also sustains the trafficking of leukocytes to sites of inflammation5. Additionally, CXCR4 signalling on other cells is involved in key migratory mechanisms during development and has been linked to the metastatic behaviour of cancer cells6,7,8,9,10,11,12. CXCR4 signalling has also been connected to tumour-sustained angiogenesis13,14,15. In particular, CXCR4 stimulation was found to induce expression of vascular endothelial growth factor (VEGF) in human breast carcinoma cells and conversely blockade of CXCL12/CXCR4 signalling was able to suppress tumour angiogenesis and tumour growth in vivo in a murine model13. Finally, CXCR4 is also well known to play a critical function in HIV pathogenesis, since this factor represents an important HIV co-receptor, mediating viral entry into the host cells16.

The existence of a viable cxcr4b knockout has made the zebrafish model particularly attractive to characterise the function of CXCR4 signalling in vivo. Originally referred to as Odysseus or Ody, zebrafish cxcr4b mutants (cxcr4b−/−) were identified in a forward genetic screen, for factors involved in the migration of primordial germ cells17. The mutation harboured by cxcr4b−/− consists in the conversion of the codon AAG in position 709–711 (coding the amino acid Lys239) into a stop codon, which determines the premature interruption of protein translation. The resulting truncated protein product lacks the third intracellular loop, the last two transmembrane domains, and the C-terminal domain, which compromises the 7-loop transmembrane architecture and therefore the capability of CXCR4 to couple with its ligand and its downstream partners (i.e. CXCL12 and heterotrimeric G-proteins)17. Similar to mammalian species, the zebrafish Cxcr4b/Cxcl12a signalling axis is also implicated in the retention and colonisation of haematopoietic tissues by haematopoietic stem cells, the recruitment of leukocytes to infectious foci and sites of injury, the invasiveness of cancer cells in tumour metastasis, and heart regeneration4,12,18,19,20.

Tuberculosis (TB) is caused by Mycobacterium tuberculosis (Mtb) infection and this disease typically manifests by the formation of aggregates of infected and non-infected immune cells that are known as granulomas. Several studies reported that human tuberculous granulomas, which frequently develop a hypoxic necrotising core, are extensively vascularised21,22,23. However, very little is understood about the actual relevance of angiogenesis for granuloma formation in TB patients. Additionally, the mechanism by which the vascularisation programme is initiated by the pathogen remains elusive24,25. In zebrafish larvae, Mycobacterium marinum (Mm), a close relative of Mtb, causes a disease that recapitulates significant aspects of human TB, which include the formation of necrotising granulomas and the initiation of specific transcriptional and morphological changes in Mycobacterium-infected macrophages26,27,28. Using the zebrafish model, it was recently found that Mm can also induce granuloma-associated angiogenesis and that initiation of this programme coincides with local induction of hypoxia and expression of the proangiogenic factor vegfaa25. Notably, the presence of macrophages was strictly necessary for mycobacterial-induced vegfaa expression and initiation of granuloma vascularisation. In tumours, activation of CXCR4/CXCL12 signalling is tightly linked to both the development of hypoxia and to the activation of angiogenesis13,14,15. Therefore, we hypothesised that this chemokine signalling axis could also be involved in granuloma-induced angiogenesis.

Here we show that Cxcr4b-deficient zebrafish larvae display an attenuated induction of the angiogenic programme at the nascent granulomas. Cellular composition of granulomas and chemotaxis of immune cells to infected areas were not altered in cxcr4b mutants compared to wt siblings. Additionally, vegfaa was still expressed in cxcr4b deficient larvae, despite the lack of granuloma vascularisation. Taken together, our study indicates that Cxcr4b-mediated signalling is required to mediate the full angiogenesis response to mycobacterial infections, and that suppression of pathological angiogenesis with CXCR4 blockers might represent an alternative therapeutic strategy to suppress granuloma-angiogenesis without perturbing VEGF signalling.

Results

Cxcr4b signalling controls granuloma-induced angiogenesis

To study granuloma-associated angiogenesis, a trunk infection model was recently established in zebrafish embryos (Fig. 1A,B). In this model a transgenic Tg(kdrl:eGFP) background (labelling arterial and venous endothelium) was used to monitor host vascularisation in the environment of the nascent granulomatous lesions (Fig. 1C–E)25,29. To study whether cxcr4b has a function in granuloma vascularisation, we injected mCherry-fluorescent Mm in cxcr4b mutant and wildtype (wt) siblings at 2 days post fertilisation (dpf) and measured bacterial expansion and angiogenesis of the infected area at 5 days post infection (dpi) (Fig. 1F–K).

Figure 1
Trunk granuloma formation and induction of angiogenesis by M. marinum.

In cxcr4b−/− larvae, the expansion of the infection progressed at a lower rate as compared to the lesions in wt (Fig. 1F–K). Simultaneously, the association of angiogenesis with the granulomas was impaired in these mutants and, differently from wt, cxcr4b mutants did not have a significant positive correlation between granuloma size and length of associated abnormal vasculature (Fig. 2A–C). Indeed, large granulomas failed to induce angiogenesis in cxcr4b−/− (Fig. 2D–I). The interdependence between granuloma expansion and angiogenesis had been previously described25 and mechanistically closely resembles the angiogenic switch in tumorigenesis, in which tumour size is directly related to the local induction of pathogenic angiogenesis30. Altogether, our findings suggest that cxcr4b mutation affects granuloma expansion by primarily affecting the initiation of the angiogenesis programme, and the difference in infection burden appears to be the consequence, rather than the cause, of impaired angiogenic support of granuloma formation. Notably, pharmacological inhibition of Cxcr4b signalling by application of two CXCR4 antagonists, namely AMD3100 and IT1t, recapitulated the angiogenesis phenotype of cxcr4b genetic knockouts with significant reduction of abnormal vasculature associated to granulomas. The strongest effect was observed in case of IT1t application, which also reduced granuloma size, highlighting the therapeutic potential of CXCR4 blockers to counteract mycobacterial diseases (Fig. 2J,K).

Figure 2
Cxcr4b mutation impairs granuloma-induced angiogenesis.

cxcr4b mutation does not alter the migratory and microbicidal capabilities of macrophages or the cellular composition of the granulomatous lesions

Intramacrophage residence of mycobacteria is indispensable for initiation of angiogenesis25. Therefore, we investigated whether the difference in promotion of angiogenesis in cxcr4b mutants could be explained by aberrant macrophage recruitment (resulting in different intracellular/extracellular ratios of Mm), differential microbicidal capability of macrophages, or alteration in the macrophage composition of granulomatous lesions. When mycobacteria were injected locally into the hindbrain ventricle, a comparable number of leukocytes were promptly recruited (3 hpi) to the infected site in mutants and wt (Fig. 3A,B). To assess the possibility of an altered microbicidal capability, we injected the Mm mutant strain Δerp, which is highly susceptible to macrophage clearance and replicates intracellularly at a low rate, thereby permitting quantification of mycobacterial growth in individual macrophages by live microscopy. At 44 hpi the percentage of macrophages displaying low (1–5 bacteria), moderate (6–10 bacteria) or high (>10 bacteria) infection load was quantified and cxcr4b mutants showed similar distribution of the infection phenotypes as wt siblings, indicating that depletion of cxcr4b does not alter the macrophage capability to counteract intracellular infection (Fig. 3C,D). We also excluded that cxcr4b mutation might affect the content of macrophages in the mature granulomas, as the percentage of mycobacteria co-localising with macrophages was similar in mutant and wt siblings (Fig. 3E–G). In zebrafish larvae, cxcr4b is expressed both by the macrophage lineage (marked by mpeg1) and by the neutrophil lineage (marked by mpx) (Fig. 3H). However, it is unlikely that the angiogenesis deficiency in cxcr4b mutants depended on cxcr4b expression by neutrophils, as suggested by irf8 morpholino knockdown, which skews myelopoiesis towards neutropoiesis at the expense of primitive macrophage development (Fig. 3I,J)31. In this situation the initial deficiency in macrophages was already sufficient to abrogate the angiogenic response, indicating that neutrophils alone cannot support angiogenesis and therefore that the cxcr4b mutation phenotype implicates a macrophage-related function. However, since recruitment of macrophages, cellular composition of lesions and intramacrophage killing of bacteria were comparable between mutants and wt (Fig. 3), we hypothesised that cxcr4b mainly affects the interaction of the macrophages with the surrounding tissue.

Figure 3
cxcr4b is not required for the establishment of macrophage parasitism, but macrophages are necessary to mediate cxcr4b-dependent angiogenesis.

Mutation of cxcr4b does not interfere with induction of Vegf signalling and with physiological angiogenesis

Since CXCR4 was previously linked to tumour angiogenesis via a transcriptional control on VEGF signalling13, we addressed whether cxcr4b mutation controlled granuloma angiogenesis by affecting Vegf signalling. Treatment with Sunitinib (a Vegf receptor inhibitor)32 or cxcr4b mutation reduced trunk granuloma size to the same level (Fig. 4A), although Vegf receptor inhibition could still synergise with cxcr4b mutation and could suppress more severely granuloma vascularisation (Fig. 4B). However, it should be noted that treatment with Sunitinib also affected to some extent physiological angiogenesis, as the frequency of physiological sprouting from intersegmental vessels (ISVs) and their fusion to the following ISV was also reduced by this treatment (Fig. 4C–E). In contrast, cxcr4b mutation affected specifically the granuloma-induced angiogenesis and not the physiological sprouting of axial vessels from ISVs. Since the angiogenesis response to mycobacterial infection was found to coincide with local induction of vegfaa25 and mammalian CXCR4 has been linked to a transcriptional regulation of VEGFA13, we addressed whether cxcr4b affected granuloma-induced angiogenesis by exerting a similar transcriptional control on vegfaa expression in our model. Whole mount qRT-PCR analysis revealed that both mutants and wt upregulated vegfaa to a comparable level (Fig. 4F). We also found that the levels of vegfaa induction, although significant, were limited (1.5-fold) when compared to the induction of other infection-inducible genes, which could be seen highly upregulated in the same conditions (Fig. 4F). Likewise, expression of cxcl12a (encoding the ligand of Cxcr4b) showed limited but comparable induction in mutants and wt (Fig. 4F). Expression of cxcr4b mRNA was not relevantly altered by the infection and remained comparable between wt and mutants (as mentioned above, the cxcr4b mutant mRNA differs from the wt only because of a non-sense point mutation and can, therefore, be normally tested by qRT-PCR). These results suggest that the reduced angiogenic response to granulomas in cxcr4b mutants is not dependent on Vegf signalling, and that Cxcr4b axis might therefore act downstream of this pathway.

Figure 4
Deficient granuloma vascularisation in cxcr4b mutation does not strictly depend on aberrant Vegf signalling or attenuated expression of inflammatory genes.

Cxcr4b mutation is associated with reduced inflammatory gene expression but il1b signalling is dispensable for granuloma angiogenesis

Signalling via CXCR4 has been linked to the induction of inflammatory genes during the response to infections33,34 and the local chronic induction of inflammation mediators is known to play a critical role to sustain angiogenesis of damaged/inflamed tissues35,36. Several inflammatory molecules (such as IL1β and TNFα) have been largely connected to the sustenance of pathological angiogenesis in inflammatory diseases35,37. In agreement, the use of the transgenic reporter Tg(il1b:eGFP-F)38 revealed high expression of il1b by Mm-infected cells composing the granulomatous lesions in zebrafish larvae (Supplementary Figure S1). Therefore, we analysed the expression profile of il1b and several other Mm-inducible inflammatory genes (tnfa, cxcl11aa, cxcl18b and mmp9)39,40,41. All these genes could be still induced in cxcr4b mutants. However, two of the analysed genes, namely cxcl18b and il1b were significantly less induced in the mutants, when compared to wt (Fig. 4F). This suggests that a differential inflammatory response can be elicited in cxcr4b mutants and wt during the infection progression. To address whether the differential induction of il1b might play a role in mediating the cxcr4b phenotype, we depleted il1b by morpholino knockdown. Morphants displayed comparable vascularisation of trunk granulomas as controls, therefore excluding that the cxcr4b mutant phenotype could be caused by reduced il1b signalling (Supplementary Figure S1).

In conclusion, our data show that Cxcr4b is required for granuloma vascularisation by a mechanism that appears to be independent from Vegf or the primary proinflammatory cytokine Il1β. Loss of Cxcr4b function limits granuloma expansion to a similar degree as Vegfr blockade, suggesting CXCR4 inhibition as an alternative host-directed therapeutic approach for TB treatment without side effects on physiological angiogenesis.

Discussion

Using intravital imaging in the zebrafish–Mm infection model, we have investigated the function of the homoeostatic chemokine receptor Cxcr4b in the development of mycobacterial infection and granuloma formation. We found that zebrafish embryos/larvae carrying a homozygote mutation of cxcr4b, developed an attenuated disease which could be associated with the inability of these mutants to induce local angiogenesis. This granuloma angiogenesis defect could be recapitulated with pharmacological inhibitors of CXCR4 (AMD3100 and IT1t). Supporting that Cxcr4b promotes granuloma formation by sustaining a mycobacteria-induced angiogenesis programme, the positive correlation between granuloma growth and angiogenesis that is normally observed in wt larvae, was lost in cxcr4b mutants. Furthermore, pharmacological blockade of the angiogenesis programme by Vegfr inhibitor could fully abolish the differences between mutants and wt in the exacerbation of mycobacterial infection. The use of angiogenesis inhibitors has previously been proposed as a host-targeted therapy to suppress the formation of granulomas in TB patients25. Based on our results, the CXCR4 receptor could be explored as a novel target for anti-angiogenic tuberculosis therapy.

It is unlikely that the granuloma angiogenesis phenotype requires expression of cxcr4b by the endothelial cells per se, since several studies have identified that venous/arterial endothelium (kdrl+) does not express high levels of cxcr4b and that this gene can be found expressed only in developing lymphatic vessels (kdrl)18,42. Our study suggests that cxcr4b function in evoking angiogenesis requires the presence of macrophages, since skewing haematopoiesis towards neutrophils at the expenses of macrophages severely affected the induction of the granuloma vascularisation. This conclusion is in line with previous data showing that macrophage depletion by transcription factor spi1/pu.1 knockdown reduced the formation of new vessels to the Mm infection foci25. Together, these results support that cxcr4b exerts its function on macrophages in a cell-autonomous fashion and affects their capability to promote angiogenesis.

Macrophages of cxcr4b mutants were normally capable of migrating to initial mycobacterial infection foci and were equally suited to contain initial intramacrophage bacterial replication, therefore excluding significant effects of cxcr4b on the establishment of mycobacteria/macrophage parasitism. Apart from the deficiency in the expansion rate and the absence of associated angiogenesis, infectious lesions of cxcr4b−/− were structurally undistinguishable from those of wt when granulomas of similar sizes were compared. Since previous studies reported that the vegfaa expression pattern coincided with the local promotion of granuloma angiogenesis25, we hypothesised that Cxcr4b might support angiogenesis via promotion of vegfaa expression. The induction levels of vegfaa in Mm infected larvae were low and we could not detect a significant difference between infected cxcr4b mutants and wt. Several studies have shown that VEGF induction in inflammatory processes can be transient and largely variable43,44,45. Therefore, a direct function of cxcr4b in the regulation of Vegf/Vegfr signalling cannot be completely excluded by our study. Interestingly, we observed a pronounced effect of Vegfr-inhibition, but not cxcr4b mutation, on the formation of physiological vessel sprouts from the intersegmental vessels, indicating that while Vegfr-inhibitors act as wide-spectrum angiogenesis blockers, cxcr4b depletion solely inhibits granuloma-induced angiogenesis.

Notably, cxcr4b mutation affected propagation of the inflammatory response, since expression of the master inflammatory gene il1b was significantly attenuated in cxcr4b mutants. Several reports showed that CXCR4 signalling can support inflammation. In particular, elegant studies revealed that CXCR4 can cross-talk with the plasma membrane Toll-like receptor TLR4 and act as a potent co-stimulatory mediator33,34. There is also growing evidence of a tight link between the angiogenesis process and inflammation, since many inflammatory molecules (prostaglandins, TNFα, interleukins such as Il1β) are proangiogenic too35,36,37,46,47. Therefore, we investigated whether curtailing inflammation via il1b depletion could phenocopy cxcr4b mutation in granuloma-angiogenesis. However, our data indicate that suppression of IL1β per se is not sufficient to abrogate the angiogenic response to the granulomas.

The relevance of inflammation in triggering granuloma-associated angiogenesis and the exact pathways by which Cxcr4b controls the proangiogenic signalling awaits a more detailed characterisation and the zebrafish model may represent an elective surrogate system to further address the angiogenesis/inflammation interplay in vivo. An attractive hypothesis is that CXCR4 signalling might control the function that macrophages exert in facilitating the engagement of endothelial cells from pre-existing vessels. Recently, macrophages have been shown to promote vascular anastomosis, a process by which neighbouring endothelial cells are connected to form new vessels, occurring in angiogenesis and de novo vasculogenesis48. Notably, this report also suggests that macrophage-mediated anastomosis acts downstream of Vegf-mediated tip cells induction, delineating a two-step model compatible with our finding that cxcr4b mutants are unable to complete the angiogenic programme, despite the fact that Vegfaa signalling is induced.

Concluding, the angiogenesis programme mounted at the granuloma is important to sustain the further expansion of the lesion and is a complex multifaceted process that involves pathogen virulence factors, macrophage response to intracellular infection and granuloma aggregation, induction of local hypoxia and VEGF signalling25. Our addition to this scenario is that the homoeostatic chemokine receptor CXCR4 is also critical to permit the induction of the angiogenic programme and to contain the propagation of inflammation. While inhibition of Vegf signalling or depletion of cxcr4b lead to comparable attenuation of granuloma expansion in the zebrafish model, blockade of Vegf signalling significantly affected also physiological vascularisation, while the effect of cxcr4b mutation was specific towards the granuloma-associated vasculature. In terms of therapeutic applications, this suggests that antagonising CXCR4 signalling might be a preferred system to specifically curtail pathological angiogenesis. Additionally, in case of TB infections, blockade of CXCR4 may represent a preferential treatment of HIV/Mtb co-infected patients. Given the fact that CXCR4 plays a relevant function in HIV entry, suppression of CXCR4 could simultaneously counteract both mycobacterial and viral infection.

Methods

Zebrafish lines and maintenance

Zebrafish lines were handled in compliance with the local animal welfare regulations and maintained according to standard protocols (zfin.org). The study was approved by the local animal welfare committee (DEC) of the University of Leiden (licence number: 10612, protocol 14227). Fish lines used in this work were the following: wildtype strain AB/TL, Tg(il1b:eGFP-Fzf550)38, Tg(fli1a:eGFPy1)49, the double transgenic line Tg(mpeg1:mCherry-Fump2/mpx:eGFPi114)50,51, cxcr4b homozygote mutant (cxcr4b−/−) and wildtype (cxcr4b+/+) siblings of (cxcr4bt26035)12,17 crossed into the transgenic backgrounds of Tg(kdrl:eGFPs843)29 or Tg(mpeg1:mCherry-Fump2). Embryos were grown at 28.5 °C in egg water (60 μg/ml sea salt, Sera Marin, Heinsberg, Germany). Larvae destined to image acquisition were maintained in egg water supplemented with 0.003% PTU (1-phenyl-2-thiourea, Sigma-Aldrich, St Louis, MO, USA) from 8–12 hpf to prevent melanisation. Anaesthesia of embryos/larvae used for live imaging was achieved with 0.02% buffered Tricaine (3-aminobenzoic acid ethyl ester, Sigma-Aldrich) in egg water.

Bacterial cultures and infection delivery

Approximately 60–100 CFU suspended in a volume of 10 nl of M. marinum strain M (or where specified its isogenic mutant strain Δerp) constitutively expressing mCherry, eGFP or mWasabi52,53 were injected into the trunk at 2 dpf25, while approximately 50 CFU in a volume of 1 nl were injected into the hindbrain (HB, 2 dpf). For recruitment assays and qRT-PCR experiments, the same volume of mock [2% polyvinylpyrrolidone-40 (Sigma-Aldrich) in phosphate buffer saline (PBS)] was injected in control embryos, as a reference control. Bacteria were grown and harvested from an O/N culture as described previously40,54. For morpholino experiments (irf8 and il1b knockdown) and collection of samples for qRT-PCR, trunk infections were performed at 33 hpf (instead of 2 dpf). For the assessment of the microbicidal activity of macrophages against initial mycobacterial infection, single cell suspensions of Mm Δerp-mWasabi were injected into the caudal vein at 33 hpf from −80 °C frozen single-use aliquots, using a protocol adapted from reference53. Briefly, bacteria from a 1-week-old plate were inoculated to an OD600 of 0.2 in 10 ml 7H9 medium supplemented with ADC enrichment. The culture was grown for 24 h to reach an OD of approximately 1.0. Bacteria were washed 3 times with PBS and suspended in PBS supplemented with 10% glycerol to an OD600 of 5.0. To generate a single cell suspension, bacteria were passed 10 times through a syringe. 50 μl aliquots were frozen in liquid nitrogen and stored at −80 °C. Upon thawing, the vital bacteria were quantified by plating as being approximately 100 CFU/nl. For quantification of macrophage and neutrophils recruitment to mycobacteria, 2 dpf embryos were infected in the hindbrain, fixed at 3 hpi in 4% paraformaldehyde in PBS supplemented with 0.08% Triton X-100 and prepared for combined L-plastin (Lp) immunostaining and myeloperoxidase (Mpx) enzymatic activity staining as in reference55. Leukocytes accumulated at the injected cavity (macrophages: Lp-positive and Mpx-negative; neutrophils: Mpx-positive) were counted using a Leica MZ16FA fluorescence stereomicroscope (Leica Microsystems, Rijswijk, The Netherlands).

RNA isolation, FACS and qRT-PCR

To evaluate the induction of genes upon infections (Fig. 4F), whole-embryo RNA extraction, cDNA synthesis and qRT-PCR were performed at 5 dpi from a pool of embryos injected at 33 hpi (4 replicates), according to the procedure described in reference40. To demonstrate expression by phagocytes (Fig. 3H), RNA was isolated from mpx+ and mpeg1+ cells sorted at 2 dpf from the double transgenic line Tg(mpeg1:mCherry-Fump2/mpx:eGFPi114), according to previous reports40,56. Reference housekeeping genes were ppia1b for whole-mount samples and eif4a1b for FACS-sorted samples. qRT-PCR primers are reported in Supplementary Table S1.

Pharmacological inhibition of VEGF and CXCR4 signalling

For pharmacological inhibition of VEGF signalling, the VEGFR tyrosine kinase inhibitor Sunitinib (1 μM, Sigma-Aldrich) or vehicle treatment (0.1% DMSO, Sigma-Aldrich), were applied directly to the egg water (immediately after infection) and refreshed every 2 days according to reference32. Similarly, for pharmacological suppression of the CXCR4 axis, we applied the CXCR4 antagonists AMD3100 (25 μM, Sigma-Aldrich)18, IT1t (20 μM, Calbiochem, Merk, Darmstadt, Germany)12 or vehicle treatment (0.1% DMSO) via bath exposure of infected embryos. In this case drugs were not refreshed during the whole experimental course.

Irf8 and il1b knockdown

All morpholinos were obtained from Gene tools. 1 nl of 1 mM irf8 splicing morpholino (5′-AATGTTTCGCTTACTTTGAAAATGG-3′)31, 1 nl of 0.6 mM il1b splicing morpholino (5′-CCCACAAACTGCAAAATATCAGCTT-3′)57,58, or the same concentration and volumes of a standard control morpholino (5′-CCTCTTACCTCAGTTACAATTTATA-3′) were injected in one-cell stage zebrafish fertilised eggs according to reference31.

Imaging and image quantification

Fixed or live embryos and larvae were imaged using a Leica MZ16FA fluorescence stereomicroscope. The size of individual granulomas was quantified at 5 dpi (at 4 dpi in case of irf8 or il1b morpholino knockdown) by pixel count, using Fiji/ImageJ software (NIH, Bethesda, MD, USA). The length of abnormal vasculature at the granulomas was quantified at the same stage from images according to reference25 and using the Tg(kdrl:eGFP) or, where specified, the Tg(fli1a:eGFP) transgenic lines. Briefly, the cumulated two-dimensional length of vessels not seen in uninfected larvae (aberrant sprouts from the dorsal longitudinal anastomic vessel or from the intersegmental vessels, and axial vessels anomalously redirected to grow towards the granulomas) was measured per each granuloma. To score the microbicidal activity of macrophages against mycobacteria, MmΔerp-mWasabi bacteria prepared as described above were injected into the caudal vein of Tg(mpeg1:mCherry-F)/cxcr4b−/− and Tg(mpeg1:mCherry-F)/cxcr4b+/+ embryos. Intramacrophage mycobacterial sites of growth were counted (blind) from fixed embryos at 44 hpi according to reference53, using Zeiss Observer 6.5.32 confocal microscope and a C-Apochromat 63x/1.20 W Korr UV-VIR-IR M27 objective (Carl Zeiss, Sliedrecht, The Netherlands). The level of infection per macrophage was classified into three groups based on bacterial content (1–5 bacteria, 6–10 bacteria or >10 bacteria). To estimate similar macrophage content of granulomas, the percentage of colocalisation of Tg(mpeg1:mCherry-F) and Mm M-eGFP was quantified ad 5 dpi using Fiji/ImageJ dedicated colocalisation plugin. Confocal images in Supplementary Figure S1 were taken from trunk granulomas at 5 dpi/6 dpf, using Zeiss Observer 6.5.32 confocal microscope and an EC Plan-Neofluar 20x/0.50 M27 (Supplementary Figure S1A) or C-Apochromat 63x/1.20W Korr UV-VIR-IR M27 objective (Supplementary Figure S1B).

Statistical analysis

Statistical significance was analysed using GraphPad Prism 6 or 7 (GraphPad Software, La Jolla, CA, USA). Differences in granuloma sizes, angiogenesis, and bacteria/macrophage co-localisation (Fig. 2A–B–J–K, Fig. 3E–I–J, Fig. 4A,B, Supplementary Figure S1C,D) were statistically tested by unpaired t-test (comparison between 2 groups) or one-way ANOVA followed by Šidák comparison test (multiple group comparisons). Difference in number of leukocytes recruited and number of physiological sprouts (Fig. 4A–B–E) were analysed by Kruskal-Wallis test for non-parametric data followed by Šidák comparison test. Bacterial cluster size/angiogenesis correlation (Fig. 2C) was analysed by Pearson correlation test and the difference between mutant and wt regressions was computed by GraphPad Prism dedicated linear regression analysis tool. Individual unpaired t-tests per each class of macrophage phenotype were used to compare the percentage of MmΔerp-infected macrophages per larva (Fig. 3C), while a chi-square contingency test was used to test the overall distribution of macrophage phenotypes (Fig. 3D).

For qRT-PCR (Fig. 4F), statistical significance was estimated by two-tailed t-tests on ln(n)-transformed relative induction folds. Significance (P-value) is indicated with: ns, non-significant; *P < 0.05; **P < 0.01; ***P < 0.001, ****P < 0.0001. Error bars: mean ± s.e.m.

Additional Information

How to cite this article: Torraca, V. et al. The chemokine receptor CXCR4 promotes granuloma formation by sustaining a mycobacteria-induced angiogenesis programme. Sci. Rep. 7, 45061; doi: 10.1038/srep45061 (2017).

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Material

Supplementary Information:

Acknowledgments

We thank Georges Lutfalla (University of Montpellier) for having provided the Tg(il1b:eGFP-F) transgenic line and all members of the fish facility team for zebrafish care. We are also grateful to Serge Mostowy, Laurence Bugeon, Natalie J. Andrews (Imperial College London), and Monica Varela (Leiden University) for making available fish lines, equipment, and for their support during the revision of this manuscript. This work was supported by the European Marie-Curie Initial Training Network FishForPharma (contract number PITN-GA-2011-289209) and by the Netherlands Organisation for Scientific Research (TOP GO Grant: 854.10.012).

Footnotes

The authors declare no competing financial interests.

Author Contributions V.T. and A.H.M. wrote the manuscript and concieved the experiments. V.T. performed the experiments and prepared figures. C.T. assisted in the mantenence and screening of the cxcr4b mutant lines. C.T. and B.E.S. provided relevant suggestions and reagents. All authors reviewed critically and accepted the manuscript.

References

  • Zou Y. R., Kottmann A. H., Kuroda M., Taniuchi I. & Littman D. R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595–599, doi: (1998).10.1038/31269 [PubMed] [Cross Ref]
  • Miller R. J., Banisadr G. & Bhattacharyya B. J. CXCR4 signaling in the regulation of stem cell migration and development. J Neuroimmunol 198, 31–38, doi: (2008).10.1016/j.jneuroim.2008.04.008 [PMC free article] [PubMed] [Cross Ref]
  • Furze R. C. & Rankin S. M. Neutrophil mobilization and clearance in the bone marrow. Immunology 125, 281–288, doi: (2008).10.1111/j.1365-2567.2008.02950.x [PubMed] [Cross Ref]
  • Walters K. B., Green J. M., Surfus J. C., Yoo S. K. & Huttenlocher A. Live imaging of neutrophil motility in a zebrafish model of WHIM syndrome. Blood 116, 2803–2811, doi: (2010).10.1182/blood-2010-03-276972 [PubMed] [Cross Ref]
  • Bleul C. C., Fuhlbrigge R. C., Casasnovas J. M., Aiuti A. & Springer T. A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 184, 1101–1109 (1996). [PMC free article] [PubMed]
  • Muller A. et al. . Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50–56, doi: (2001).10.1038/35065016 [PubMed] [Cross Ref]
  • Fricker S. P. A novel CXCR4 antagonist for hematopoietic stem cell mobilization. Expert Opin Investig Drugs 17, 1749–1760, doi: (2008).10.1517/13543784.17.11.1749 [PubMed] [Cross Ref]
  • Uy G. L., Rettig M. P. & Cashen A. F. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells. Expert Opin Biol Ther 8, 1797–1804, doi: (2008).10.1517/14712598.8.11.1797 [PubMed] [Cross Ref]
  • Doitsidou M. et al. . Guidance of primordial germ cell migration by the chemokine SDF-1. Cell 111, 647–659 (2002). [PubMed]
  • Gelmini S., Mangoni M., Serio M., Romagnani P. & Lazzeri E. The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis. J Endocrinol Invest 31, 809–819, doi: (2008).10.1007/BF03349262 [PubMed] [Cross Ref]
  • Mukherjee S. et al. . Non-migratory tumorigenic intrinsic cancer stem cells ensure breast cancer metastasis by generation of CXCR4(+) migrating cancer stem cells. Oncogene 35, 4937–4948, doi: (2016).10.1038/onc.2016.26 [PubMed] [Cross Ref]
  • Tulotta C. et al. . Inhibition of signaling between human CXCR4 and zebrafish ligands by the small molecule IT1t impairs the formation of triple-negative breast cancer early metastases in a zebrafish xenograft model. Dis Model Mech 9, 141–153, doi: (2016).10.1242/dmm.023275 [PMC free article] [PubMed] [Cross Ref]
  • Liang Z. et al. . CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway. Biochem Biophys Res Commun 359, 716–722, doi: (2007).10.1016/j.bbrc.2007.05.182 [PMC free article] [PubMed] [Cross Ref]
  • Massena S. et al. . Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans. Blood 126, 2016–2026, doi: (2015).10.1182/blood-2015-03-631572 [PubMed] [Cross Ref]
  • Katkoori V. R., Basson M. D., Bond V. C., Manne U. & Bumpers H. L. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers. Oncotarget 6, 27763–27777, doi: (2015).10.18632/oncotarget.4615 [PMC free article] [PubMed] [Cross Ref]
  • Alkhatib G. & Berger E. A. HIV coreceptors: from discovery and designation to new paradigms and promise. Eur J Med Res 12, 375–384 (2007). [PubMed]
  • Knaut H., Werz C., Geisler R., Nusslein-Volhard C. & Tubingen Screen C. A zebrafish homologue of the chemokine receptor Cxcr4 is a germ-cell guidance receptor. Nature 421, 279–282, doi: (2003).10.1038/nature01338 [PubMed] [Cross Ref]
  • Tamplin O. J. et al. . Hematopoietic stem cell arrival triggers dynamic remodeling of the perivascular niche. Cell 160, 241–252, doi: (2015).10.1016/j.cell.2014.12.032 [PMC free article] [PubMed] [Cross Ref]
  • Raz E. & Mahabaleshwar H. Chemokine signaling in embryonic cell migration: a fisheye view. Development 136, 1223–1229, doi: (2009).10.1242/dev.022418 [PubMed] [Cross Ref]
  • Itou J. et al. . Migration of cardiomyocytes is essential for heart regeneration in zebrafish. Development 139, 4133–4142, doi: (2012).10.1242/dev.079756 [PubMed] [Cross Ref]
  • Alatas F. et al. . Vascular endothelial growth factor levels in active pulmonary tuberculosis. Chest 125, 2156–2159 (2004). [PubMed]
  • Matsuyama W. et al. . Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis. Am J Respir Crit Care Med 162, 1120–1122, doi: (2000).10.1164/ajrccm.162.3.9911010 [PubMed] [Cross Ref]
  • Tsai M. C. et al. . Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbiol 8, 218–232, doi: (2006).10.1111/j.1462-5822.2005.00612.x [PubMed] [Cross Ref]
  • Saita N., Fujiwara N., Yano I., Soejima K. & Kobayashi K. Trehalose 6,6′-dimycolate (cord factor) of Mycobacterium tuberculosis induces corneal angiogenesis in rats. Infect Immun 68, 5991–5997 (2000). [PMC free article] [PubMed]
  • Oehlers S. H. et al. . Interception of host angiogenic signalling limits mycobacterial growth. Nature 517, 612–615, doi: (2015).10.1038/nature13967 [PMC free article] [PubMed] [Cross Ref]
  • Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol 12, 352–366, doi: (2012).10.1038/nri3211 [PubMed] [Cross Ref]
  • Meijer A. H. Protection and pathology in TB: learning from the zebrafish model. Semin Immunopathol 38, 261–273, doi: (2016).10.1007/s00281-015-0522-4 [PMC free article] [PubMed] [Cross Ref]
  • Cronan M. R. et al. . Macrophage Epithelial Reprogramming Underlies Mycobacterial Granuloma Formation and Promotes Infection. Immunity 45, 861–876, doi: (2016).10.1016/j.immuni.2016.09.014 [PubMed] [Cross Ref]
  • Jin S. W., Beis D., Mitchell T., Chen J. N. & Stainier D. Y. Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. Development 132, 5199–5209, doi: (2005).10.1242/dev.02087 [PubMed] [Cross Ref]
  • Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29, 15–18, doi: (2002).10.1053/sonc.2002.37263 [PubMed] [Cross Ref]
  • Li L., Jin H., Xu J., Shi Y. & Wen Z. Irf8 regulates macrophage versus neutrophil fate during zebrafish primitive myelopoiesis. Blood 117, 1359–1369, doi: (2011).10.1182/blood-2010-06-290700 [PubMed] [Cross Ref]
  • He S. et al. . Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model. J Pathol 227, 431–445, doi: (2012).10.1002/path.4013 [PMC free article] [PubMed] [Cross Ref]
  • Triantafilou M. et al. . Chemokine receptor 4 (CXCR4) is part of the lipopolysaccharide “sensing apparatus”. Eur J Immunol 38, 192–203, doi: (2008).10.1002/eji.200636821 [PubMed] [Cross Ref]
  • Kishore S. P., Bungum M. K., Platt J. L. & Brunn G. J. Selective suppression of Toll-like receptor 4 activation by chemokine receptor 4. FEBS Lett 579, 699–704, doi: (2005).10.1016/j.febslet.2004.12.047 [PubMed] [Cross Ref]
  • Naldini A. & Carraro F. Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy 4, 3–8 (2005). [PubMed]
  • Jackson J. R., Seed M. P., Kircher C. H., Willoughby D. A. & Winkler J. D. The codependence of angiogenesis and chronic inflammation. FASEB J 11, 457–465 (1997). [PubMed]
  • Carmi Y. et al. . The role of IL-1beta in the early tumor cell-induced angiogenic response. J Immunol 190, 3500–3509, doi: (2013).10.4049/jimmunol.1202769 [PubMed] [Cross Ref]
  • Nguyen-Chi M. et al. . Transient infection of the zebrafish notochord with E. coli induces chronic inflammation. Dis Model Mech 7, 871–882, doi: (2014).10.1242/dmm.014498 [PMC free article] [PubMed] [Cross Ref]
  • van der Vaart M., van Soest J. J., Spaink H. P. & Meijer A. H. Functional analysis of a zebrafish myd88 mutant identifies key transcriptional components of the innate immune system. Dis Model Mech 6, 841–854, doi: (2013).10.1242/dmm.010843 [PMC free article] [PubMed] [Cross Ref]
  • Torraca V. et al. . The CXCR3-CXCL11 signaling axis mediates macrophage recruitment and dissemination of mycobacterial infection. Dis Model Mech 8, 253–269, doi: (2015).10.1242/dmm.017756 [PMC free article] [PubMed] [Cross Ref]
  • Torraca V., Otto N. A., Tavakoli-Tameh A. & Meijer A. H. The inflammatory chemokine Cxcl18b exerts neutrophil-specific chemotaxis via the promiscuous chemokine receptor Cxcr2 in zebrafish. Dev Comp Immunol 67, 57–65, doi: (2017).10.1016/j.dci.2016.10.014 [PubMed] [Cross Ref]
  • Cha Y. R. et al. . Chemokine signaling directs trunk lymphatic network formation along the preexisting blood vasculature. Dev Cell 22, 824–836, doi: (2012).10.1016/j.devcel.2012.01.011 [PMC free article] [PubMed] [Cross Ref]
  • Hudlicka O., Milkiewicz M., Cotter M. A. & Brown M. D. Hypoxia and expression of VEGF-A protein in relation to capillary growth in electrically stimulated rat and rabbit skeletal muscles. Exp Physiol 87, 373–381 (2002). [PubMed]
  • Stone J. et al. . Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15, 4738–4747 (1995). [PubMed]
  • Datta M. et al. . Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery. Proc Natl Acad Sci USA 112, 1827–1832, doi: (2015).10.1073/pnas.1424563112 [PubMed] [Cross Ref]
  • Voronov E., Carmi Y. & Apte R. N. The role IL-1 in tumor-mediated angiogenesis. Front Physiol 5, 114, doi: (2014).10.3389/fphys.2014.00114 [PMC free article] [PubMed] [Cross Ref]
  • Voronov E. et al. . IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 100, 2645–2650, doi: (2003).10.1073/pnas.0437939100 [PubMed] [Cross Ref]
  • Fantin A. et al. . Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 116, 829–840, doi: (2010).10.1182/blood-2009-12-257832 [PubMed] [Cross Ref]
  • Lawson N. D. & Weinstein B. M. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol 248, 307–318 (2002). [PubMed]
  • Bernut A. et al. . Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation. Proc Natl Acad Sci USA 111, E943–952, doi: (2014).10.1073/pnas.1321390111 [PubMed] [Cross Ref]
  • Renshaw S. A. et al. . A transgenic zebrafish model of neutrophilic inflammation. Blood 108, 3976–3978, doi: (2006).10.1182/blood-2006-05-024075 [PubMed] [Cross Ref]
  • van der Sar A. M. et al. . Mycobacterium marinum strains can be divided into two distinct types based on genetic diversity and virulence. Infect Immun 72, 6306–6312, doi: (2004).10.1128/IAI.72.11.6306-6312.2004 [PMC free article] [PubMed] [Cross Ref]
  • Takaki K., Davis J. M., Winglee K. & Ramakrishnan L. Evaluation of the pathogenesis and treatment of Mycobacterium marinum infection in zebrafish. Nat Protoc 8, 1114–1124, doi: (2013).10.1038/nprot.2013.068 [PMC free article] [PubMed] [Cross Ref]
  • Benard E. L. et al. . Infection of zebrafish embryos with intracellular bacterial pathogens. J Vis Exp, doi: (2012).10.3791/3781 [PubMed] [Cross Ref]
  • Cui C. et al. . Infectious disease modeling and innate immune function in zebrafish embryos. Methods Cell Biol 105, 273–308, doi: (2011).10.1016/B978-0-12-381320-6.00012-6 [PubMed] [Cross Ref]
  • Rougeot J. et al. . RNA sequencing of FACS-sorted immune cell populations from zebrafish infection models to identify cell specific responses to intracellular pathogens. Methods Mol Biol 1197, 261–274, doi: (2014).10.1007/978-1-4939-1261-2_15 [PubMed] [Cross Ref]
  • Candel S. et al. . Tnfa signaling through tnfr2 protects skin against oxidative stress-induced inflammation. PLoS Biol 12, e1001855, doi: (2014).10.1371/journal.pbio.1001855 [PMC free article] [PubMed] [Cross Ref]
  • Lopez-Munoz A. et al. . Evolutionary conserved pro-inflammatory and antigen presentation functions of zebrafish IFNgamma revealed by transcriptomic and functional analysis. Mol Immunol 48, 1073–1083, doi: (2011).10.1016/j.molimm.2011.01.015 [PubMed] [Cross Ref]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group